Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.53 |
| ▸ | CRHR1 | P34998 | 7/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CTH | P32929 | 1/20 | 0.38 |
| ▸ | CDC7 | O00311 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.33 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.33 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6961020 | 0.89 | SLC29A1 (0.46) | SLC29A1CRHR1SMN1; SMN2MAPTCTH | |
| SCHEMBL12994846 | 0.86 | SLC29A1 (0.44) | SLC29A1CRHR1SMN1; SMN2MAPTCTH | |
| SCHEMBL16284291 | 0.77 | CRHR1 (0.49) | SLC29A1CRHR1SMN1; SMN2MAPTCYP3A4 | |
| SCHEMBL10377680 | 0.75 | SLC29A1 (0.40) | SLC29A1CRHR1CTHCDC7MEN1 | |
| SCHEMBL8108845 | 0.75 | SLC29A1 (0.39) | SLC29A1CRHR1SMN1; SMN2CTHCDC7 | |
| SCHEMBL14029791 | 0.74 | DYRK1A (0.44) | SLC29A1CRHR1SMN1; SMN2CDC7DYRK1A | |
| SCHEMBL123963 | 0.72 | ALDH1A1 (0.38) | SLC29A1CRHR1SMN1; SMN2MAPTLMNA | |
| SCHEMBL26134280 | 0.72 | ALDH1A1 (0.38) | SLC29A1CRHR1SMN1; SMN2MAPTLMNA | |
| SCHEMBL7469761 | 0.72 | SLC29A1 (0.37) | SLC29A1CRHR1SMN1; SMN2CTHCDC7 | |
| SCHEMBL22022706 | 0.72 | HTT (0.33) | SLC29A1CRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142446-A1 | ACIDIC AQUEOUS COMPOSITION FOR ELECTROLYTICALLY DEPOSITING A COPPER DEPOSIT | Atotech Deutschland GmbH & Co. KG (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20200326623-A1 | A NEGATIVE TONE LIFT OFF RESIST COMPOSITION COMPRISING AN ALKALI SOLUBLE RESIN AND CROSS LINKERS AND A METHOD FOR MANUFACTURING METAL FILM PATTERNS ON A SUBSTRATE | MERCK PATENT GMBH (DE) | 2020-10-15 | — | — | US | disclosed |
| US-8158308-B2 | Including heterocyclic monofunctional thiol compound; storage stability; developability at high sensitivity; formation of fine rectangular pattern at low binder levels | FUJIFILM CORPORATION (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20080226994-A1 | NEGATIVE CURABLE COMPOSITION, COLOR FILTER, AND METHOD OF PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2008-09-18 | — | — | US | disclosed |
| EP-1970759-A1 | Negative curable composition, color filter, and method of producing the same | Fujifilm Corporation (JP) | 2008-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142446-A1 | ACIDIC AQUEOUS COMPOSITION FOR ELECTROLYTICALLY DEPOSITING A COPPER DEPOSIT | PCNA, WASHC5, POLR1C | SLC29A1 3345/4885CRHR1 3383/4885SMN1; SMN2 4017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.